Chronic Anticoagulation Fails to Lower AKI Risk in COVID-19 Patients

Pavankumar Kamat

Disclosures

July 09, 2021

Takeaway

  • Chronic anticoagulation does not reduce the risk of acute kidney injury (AKI) and its severity, including the need for renal replacement therapy (RRT) in hospitalised patients with COVID-19.

Why this matters

  • Findings suggest that renal microvascular thrombosis is unlikely to play a vital role in COVID-19-related AKI, which is more likely to be multifactorial, warranting early detection and management.

Study design

  • A retrospective study reviewed electronic records of 1032 patients with COVID-19 (age, >18 years) who were admitted to Manchester University Foundation Trust Hospitals between 10 March and 30 April 2020.

  • AKI was classified according to the Kidney Disease Improving Global Outcomes criteria.

  • Funding: None.

Key results

  • Of the 1032 patients, 164 (15.9%) received anticoagulant therapy prior to hospital admission.

  • No significant difference was seen between patients who received anticoagulants and those who did not in:

    • rates of AKI (23.8% vs 19.7%; P=.278);

    • severity of AKI stage III (48.7% vs 42.7%; P=.783); and

    • need for RRT (1.2% vs 3.5%; P=.204).

  • In multivariate analysis, anticoagulation was not associated with AKI (OR, 1.02; 95% CI, 0.60-1.68; P=.952).

  • Risk factors for AKI were (OR; 95% CI):

    • pre-existing renal disease (2.31; 1.42-3.72; P=.001);

    • hypertension (1.61; 1.07-2.46; P=.024); and

    • male gender (1.65; 1.11-2.49; P=.015).

Limitations

  • Retrospective.

 

Parker K, Hamilton P, Hanumapura P, Castelino L, Murphy M, Challiner R, Thachil J, Ebah L. Chronic anticoagulation is not associated with a reduced risk of acute kidney injury in hospitalised Covid-19 patients. BMC Nephrol. 2021;22(1):224. doi: 10.1186/s12882-021-02436-5. PMID: 34134645.  View full text

This clinical summary originally appeared on Univadis, part of the Medscape Professional Network.

Comments

3090D553-9492-4563-8681-AD288FA52ACE
Comments on Medscape are moderated and should be professional in tone and on topic. You must declare any conflicts of interest related to your comments and responses. Please see our Commenting Guide for further information. We reserve the right to remove posts at our sole discretion.
Post as:

processing....